MKI67 and central nervous system cancer: By correlating these metabolic variations with Ki-67 levels, our findings complement Yao et al.'s biochemical insights, underscoring the importance of integrating metabolic, genetic, and molecular markers to improve glioma diagnosis and therapeutic planning.